Filtrar
Cerrar

Sartorius Stedim Biotech Acquires BioOutsource

jueves, 17 de diciembre de 2015

Sartorius Stedim Biotech (SSB) acquired Glasgow-based BioOutsource, which  provides contract testing services—monitoring the safety and quality of biologicals and vaccines—to global biopharmaceutical clients. The privately owned firm, with 85 employees, earned revenue of around €9 million over the past 12 months.

“By adding contract testing services, we will be able to support our biopharma clients even better in their drive to fast-track their new drug candidates through the development and clinical test phases and facilitate lot release testing in large scale manufacturing,” noted Reinhard Vogt, member of SSB’s board. “The highly qualified team at BioOutsource will ideally complement our expertise, and we are looking forward to working with them.”

Deja tu comentario